Better Shareholder Health
Shareholders are an important stakeholder to Mylan, and we believe that by continuing to do good, we will continue to do well by them. Robust shareholder engagement remains a priority for Mylan’s board and management as the company continues to drive long-term shareholder value while also striving to serve the interests of other stakeholders in a complex and evolving healthcare environment. We are committed to maintaining a dialogue with our shareholders to ensure that they understand our differentiated strategy and business model and that together we take the opportunity to discuss and engage on topics of interest regarding their investment in Mylan.
Throughout 2017 the diverse views of our shareholders were relayed to the board on topics including social responsibility, board dynamics, risk oversight, corporate strategy and executive compensation. As part of our expanding effort on global social responsibility, we will work throughout 2018 and 2019 to:
- Identify and prioritize the most relevant ESG topics for our business, including identifying their potential impact on
- conduct an inventory of relevant policies and activities to identify opportunities to improve our performance and communication
related to the ESG topics most relevant to Mylan and its key stakeholders. This will help determine a performance baseline and
inform the establishment of relevant ESG goals, key performance indicators and metrics;
- engage with a cross-section of stakeholders to evaluate needs, concerns and expectations regarding Mylan and applicable ESG
- expand our ESG disclosures around the topics of highest overall relevance as well as those of interest to the investment
community and other stakeholder groups.